APO Research
Talk to an analyst

APO RESEARCH · REPORT

Peptide Conjugates Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Peptide Conjugates Service Industry Growth and Trends Forecast to 2032

5 June 2026110 pages

Choose your research edition.

Industry ResearchPeptide Conjugates Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Peptide Conjugates Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Peptide Conjugates Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Peptide Conjugates Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Peptide Conjugates Service Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

According to APO Research, the global Peptide Conjugates Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Peptide Conjugates Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Peptide Conjugates Service market include Almac Group, Bio-Synthesis, Creative Peptides, ProtaGene GmbH, WuXi TIDES, Medtide Inc, Ajinomoto, PHARMARON and SBS Genetech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Peptide Conjugates Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Peptide Conjugates Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Peptide Conjugates Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Peptide Conjugates Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Peptide Conjugates Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Peptide Conjugates Service Market by Company

Almac Group

Bio-Synthesis

Creative Peptides

ProtaGene GmbH

WuXi TIDES

Medtide Inc

Ajinomoto

PHARMARON

SBS Genetech

Creative Enzymes

AnaSpec

BOCSCI Inc

JPT Peptide Technologies

Kaneka Eurogentec SA

QYAOBIO

Peptide Conjugates Service Segment by Type

Peptide Oligonucleotide Conjugates

Peptide Carrier Protein Conjugates

Peptide Small Molecule Conjugates

Other

Peptide Conjugates Service Segment by Application

Vaccine Development

Drug Delivery

Biomarkers

Peptide Conjugates Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Conjugates Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Peptide Conjugates Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Conjugates Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Peptide Conjugates Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Peptide Conjugates Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Peptide Conjugates Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Peptide Conjugates Service Market Share by Region (2021-2026) Table 4. Global Peptide Conjugates Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Peptide Conjugates Service Market Share by Region (2027-2032) Table 6. Global Peptide Conjugates Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Peptide Conjugates Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Peptide Conjugates Service Market Size Share by Type (2021-2026) Table 9. Global Peptide Conjugates Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Peptide Conjugates Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Peptide Conjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Peptide Conjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Peptide Conjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Peptide Conjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Peptide Conjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Peptide Conjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Peptide Conjugates Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Peptide Conjugates Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Peptide Conjugates Service Market Size Share by Application (2021-2026) Table 24. Global Peptide Conjugates Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Peptide Conjugates Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Peptide Conjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Peptide Conjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Peptide Conjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Peptide Conjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Peptide Conjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Peptide Conjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Peptide Conjugates Service Industry Trends Table 37. Peptide Conjugates Service Industry Drivers Table 38. Peptide Conjugates Service Industry Opportunities and Challenges Table 39. Peptide Conjugates Service Industry Restraints Table 40. Global Peptide Conjugates Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Peptide Conjugates Service Revenue Market Share by Company (2021-2026) Table 42. Global Peptide Conjugates Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Peptide Conjugates Service Key Company Headquarters & Area Served Table 44. Global Peptide Conjugates Service Company, Product Type & Application Table 45. Global Peptide Conjugates Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Peptide Conjugates Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Almac Group Company Information Table 49. Almac Group Business Overview Table 50. Almac Group Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Almac Group Peptide Conjugates Service Product Portfolio Table 52. Almac Group Recent Development Table 53. Bio-Synthesis Company Information Table 54. Bio-Synthesis Business Overview Table 55. Bio-Synthesis Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Bio-Synthesis Peptide Conjugates Service Product Portfolio Table 57. Bio-Synthesis Recent Development Table 58. Creative Peptides Company Information Table 59. Creative Peptides Business Overview Table 60. Creative Peptides Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Creative Peptides Peptide Conjugates Service Product Portfolio Table 62. Creative Peptides Recent Development Table 63. ProtaGene GmbH Company Information Table 64. ProtaGene GmbH Business Overview Table 65. ProtaGene GmbH Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ProtaGene GmbH Peptide Conjugates Service Product Portfolio Table 67. ProtaGene GmbH Recent Development Table 68. WuXi TIDES Company Information Table 69. WuXi TIDES Business Overview Table 70. WuXi TIDES Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. WuXi TIDES Peptide Conjugates Service Product Portfolio Table 72. WuXi TIDES Recent Development Table 73. Medtide Inc Company Information Table 74. Medtide Inc Business Overview Table 75. Medtide Inc Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Medtide Inc Peptide Conjugates Service Product Portfolio Table 77. Medtide Inc Recent Development Table 78. Ajinomoto Company Information Table 79. Ajinomoto Business Overview Table 80. Ajinomoto Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Ajinomoto Peptide Conjugates Service Product Portfolio Table 82. Ajinomoto Recent Development Table 83. PHARMARON Company Information Table 84. PHARMARON Business Overview Table 85. PHARMARON Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. PHARMARON Peptide Conjugates Service Product Portfolio Table 87. PHARMARON Recent Development Table 88. SBS Genetech Company Information Table 89. SBS Genetech Business Overview Table 90. SBS Genetech Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. SBS Genetech Peptide Conjugates Service Product Portfolio Table 92. SBS Genetech Recent Development Table 93. Creative Enzymes Company Information Table 94. Creative Enzymes Business Overview Table 95. Creative Enzymes Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Creative Enzymes Peptide Conjugates Service Product Portfolio Table 97. Creative Enzymes Recent Development Table 98. AnaSpec Company Information Table 99. AnaSpec Business Overview Table 100. AnaSpec Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AnaSpec Peptide Conjugates Service Product Portfolio Table 102. AnaSpec Recent Development Table 103. BOCSCI Inc Company Information Table 104. BOCSCI Inc Business Overview Table 105. BOCSCI Inc Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. BOCSCI Inc Peptide Conjugates Service Product Portfolio Table 107. BOCSCI Inc Recent Development Table 108. JPT Peptide Technologies Company Information Table 109. JPT Peptide Technologies Business Overview Table 110. JPT Peptide Technologies Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. JPT Peptide Technologies Peptide Conjugates Service Product Portfolio Table 112. JPT Peptide Technologies Recent Development Table 113. Kaneka Eurogentec SA Company Information Table 114. Kaneka Eurogentec SA Business Overview Table 115. Kaneka Eurogentec SA Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Kaneka Eurogentec SA Peptide Conjugates Service Product Portfolio Table 117. Kaneka Eurogentec SA Recent Development Table 118. QYAOBIO Company Information Table 119. QYAOBIO Business Overview Table 120. QYAOBIO Peptide Conjugates Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. QYAOBIO Peptide Conjugates Service Product Portfolio Table 122. QYAOBIO Recent Development Table 123. North America Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Peptide Conjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Peptide Conjugates Service Market Share by Country (2021-2026) Table 126. North America Peptide Conjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Peptide Conjugates Service Market Share Forecast by Country (2027-2032) Table 128. Europe Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Peptide Conjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Peptide Conjugates Service Market Share by Country (2021-2026) Table 131. Europe Peptide Conjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Peptide Conjugates Service Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Peptide Conjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Peptide Conjugates Service Market Share by Country (2021-2026) Table 136. Asia-Pacific Peptide Conjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Peptide Conjugates Service Market Share Forecast by Country (2027-2032) Table 138. Latin America Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Peptide Conjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Peptide Conjugates Service Market Share by Country (2021-2026) Table 141. Latin America Peptide Conjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Peptide Conjugates Service Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Peptide Conjugates Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Peptide Conjugates Service Market Share by Country (2021-2026) Table 146. Middle East & Africa Peptide Conjugates Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Peptide Conjugates Service Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Peptide Conjugates Service Product Image Figure 3. Global Peptide Conjugates Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Peptide Conjugates Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Peptide Conjugates Service Market Share by Region: 2025 VS 2032 Figure 6. Global Peptide Conjugates Service Market Share by Region (2021-2032) Figure 7. North America Peptide Conjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Peptide Conjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Peptide Conjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Peptide Conjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Peptide Conjugates Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Peptide Oligonucleotide Conjugates Image Figure 13. Global Peptide Oligonucleotide Conjugates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Peptide Carrier Protein Conjugates Image Figure 15. Global Peptide Carrier Protein Conjugates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Peptide Small Molecule Conjugates Image Figure 17. Global Peptide Small Molecule Conjugates Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Peptide Conjugates Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Peptide Conjugates Service Market Share by Type 2025 VS 2032 Figure 22. North America Peptide Conjugates Service Market Size Share by Type (2021-2032) Figure 23. Europe Peptide Conjugates Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Peptide Conjugates Service Market Size Share by Type (2021-2032) Figure 25. Latin America Peptide Conjugates Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Peptide Conjugates Service Market Size Share by Type (2021-2032) Figure 27. Vaccine Development Image Figure 28. Global Vaccine Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Drug Delivery Image Figure 30. Global Drug Delivery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Biomarkers Image Figure 32. Global Biomarkers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Peptide Conjugates Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Peptide Conjugates Service Market Share by Application 2025 VS 2032 Figure 35. North America Peptide Conjugates Service Market Size Share by Application (2021-2032) Figure 36. Europe Peptide Conjugates Service Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Peptide Conjugates Service Market Size Share by Application (2021-2032) Figure 38. Latin America Peptide Conjugates Service Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Peptide Conjugates Service Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Peptide Conjugates Service Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Peptide Conjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Peptide Conjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Peptide Conjugates Service Market Share by Country (2021-2032) Figure 45. Europe Peptide Conjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Peptide Conjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Peptide Conjugates Service Market Share by Country (2021-2032) Figure 48. Asia-Pacific Peptide Conjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Peptide Conjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Peptide Conjugates Service Market Share by Country (2021-2032) Figure 51. Latin America Peptide Conjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Peptide Conjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Peptide Conjugates Service Market Share by Country (2021-2032) Figure 54. Middle East & Africa Peptide Conjugates Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Peptide Conjugates Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Peptide Conjugates Service Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Peptide Oligonucleotide Conjugates
  • Peptide Carrier Protein Conjugates
  • Peptide Small Molecule Conjugates
  • Other
Applications
  • Vaccine Development
  • Drug Delivery
  • Biomarkers
Companies covered
  • Almac Group
  • Bio-Synthesis
  • Creative Peptides
  • ProtaGene GmbH
  • WuXi TIDES
  • Medtide Inc
  • Ajinomoto
  • PHARMARON
  • SBS Genetech
  • Creative Enzymes
  • AnaSpec
  • BOCSCI Inc
  • JPT Peptide Technologies
  • Kaneka Eurogentec SA
  • QYAOBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Peptide Conjugates Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Peptide Conjugates Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Peptide Conjugates Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Peptide Conjugates Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Peptide Conjugates Service Market Size (2021-2032)
  8. 1.5.1 North America Peptide Conjugates Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Peptide Conjugates Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Peptide Conjugates Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Peptide Conjugates Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Peptide Conjugates Service Market Size Growth Rate (2021-2032)
2 Peptide Conjugates Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Peptide Oligonucleotide Conjugates
  3. 2.1.2 Peptide Carrier Protein Conjugates
  4. 2.1.3 Peptide Small Molecule Conjugates
  5. 2.1.4 Other
  6. 2.2 Global Peptide Conjugates Service Market Size by Type
  7. 2.2.1 Global Peptide Conjugates Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Peptide Conjugates Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Peptide Conjugates Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Peptide Conjugates Service Market Size by Regions
  11. 2.3.1 North America Peptide Conjugates Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Peptide Conjugates Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Peptide Conjugates Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Type (2021-2026)
3 Peptide Conjugates Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Vaccine Development
  3. 3.1.2 Drug Delivery
  4. 3.1.3 Biomarkers
  5. 3.2 Global Peptide Conjugates Service Market Size by Application
  6. 3.2.1 Global Peptide Conjugates Service Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Peptide Conjugates Service Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Peptide Conjugates Service Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Peptide Conjugates Service Market Size by Regions
  10. 3.3.1 North America Peptide Conjugates Service Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Peptide Conjugates Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Peptide Conjugates Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Peptide Conjugates Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Peptide Conjugates Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Peptide Conjugates Service Industry Trends
  2. 4.2 Peptide Conjugates Service Industry Drivers
  3. 4.3 Peptide Conjugates Service Industry Opportunities and Challenges
  4. 4.4 Peptide Conjugates Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Peptide Conjugates Service Revenue (2021-2026)
  2. 5.2 Global Peptide Conjugates Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Peptide Conjugates Service Key Company Headquarters & Area Served
  4. 5.4 Global Peptide Conjugates Service Company, Product Type & Application
  5. 5.5 Global Peptide Conjugates Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Peptide Conjugates Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Peptide Conjugates Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Peptide Conjugates Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Almac Group
  2. 6.1.1 Almac Group Company Information
  3. 6.1.2 Almac Group Business Overview
  4. 6.1.3 Almac Group Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Almac Group Peptide Conjugates Service Product Portfolio
  6. 6.1.5 Almac Group Recent Developments
  7. 6.2 Bio-Synthesis
  8. 6.2.1 Bio-Synthesis Company Information
  9. 6.2.2 Bio-Synthesis Business Overview
  10. 6.2.3 Bio-Synthesis Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Bio-Synthesis Peptide Conjugates Service Product Portfolio
  12. 6.2.5 Bio-Synthesis Recent Developments
  13. 6.3 Creative Peptides
  14. 6.3.1 Creative Peptides Company Information
  15. 6.3.2 Creative Peptides Business Overview
  16. 6.3.3 Creative Peptides Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Creative Peptides Peptide Conjugates Service Product Portfolio
  18. 6.3.5 Creative Peptides Recent Developments
  19. 6.4 ProtaGene GmbH
  20. 6.4.1 ProtaGene GmbH Company Information
  21. 6.4.2 ProtaGene GmbH Business Overview
  22. 6.4.3 ProtaGene GmbH Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ProtaGene GmbH Peptide Conjugates Service Product Portfolio
  24. 6.4.5 ProtaGene GmbH Recent Developments
  25. 6.5 WuXi TIDES
  26. 6.5.1 WuXi TIDES Company Information
  27. 6.5.2 WuXi TIDES Business Overview
  28. 6.5.3 WuXi TIDES Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 WuXi TIDES Peptide Conjugates Service Product Portfolio
  30. 6.5.5 WuXi TIDES Recent Developments
  31. 6.6 Medtide Inc
  32. 6.6.1 Medtide Inc Company Information
  33. 6.6.2 Medtide Inc Business Overview
  34. 6.6.3 Medtide Inc Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Medtide Inc Peptide Conjugates Service Product Portfolio
  36. 6.6.5 Medtide Inc Recent Developments
  37. 6.7 Ajinomoto
  38. 6.7.1 Ajinomoto Company Information
  39. 6.7.2 Ajinomoto Business Overview
  40. 6.7.3 Ajinomoto Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Ajinomoto Peptide Conjugates Service Product Portfolio
  42. 6.7.5 Ajinomoto Recent Developments
  43. 6.8 PHARMARON
  44. 6.8.1 PHARMARON Company Information
  45. 6.8.2 PHARMARON Business Overview
  46. 6.8.3 PHARMARON Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 PHARMARON Peptide Conjugates Service Product Portfolio
  48. 6.8.5 PHARMARON Recent Developments
  49. 6.9 SBS Genetech
  50. 6.9.1 SBS Genetech Company Information
  51. 6.9.2 SBS Genetech Business Overview
  52. 6.9.3 SBS Genetech Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 SBS Genetech Peptide Conjugates Service Product Portfolio
  54. 6.9.5 SBS Genetech Recent Developments
  55. 6.10 Creative Enzymes
  56. 6.10.1 Creative Enzymes Company Information
  57. 6.10.2 Creative Enzymes Business Overview
  58. 6.10.3 Creative Enzymes Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Creative Enzymes Peptide Conjugates Service Product Portfolio
  60. 6.10.5 Creative Enzymes Recent Developments
  61. 6.11 AnaSpec
  62. 6.11.1 AnaSpec Company Information
  63. 6.11.2 AnaSpec Business Overview
  64. 6.11.3 AnaSpec Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AnaSpec Peptide Conjugates Service Product Portfolio
  66. 6.11.5 AnaSpec Recent Developments
  67. 6.12 BOCSCI Inc
  68. 6.12.1 BOCSCI Inc Company Information
  69. 6.12.2 BOCSCI Inc Business Overview
  70. 6.12.3 BOCSCI Inc Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 BOCSCI Inc Peptide Conjugates Service Product Portfolio
  72. 6.12.5 BOCSCI Inc Recent Developments
  73. 6.13 JPT Peptide Technologies
  74. 6.13.1 JPT Peptide Technologies Company Information
  75. 6.13.2 JPT Peptide Technologies Business Overview
  76. 6.13.3 JPT Peptide Technologies Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 JPT Peptide Technologies Peptide Conjugates Service Product Portfolio
  78. 6.13.5 JPT Peptide Technologies Recent Developments
  79. 6.14 Kaneka Eurogentec SA
  80. 6.14.1 Kaneka Eurogentec SA Company Information
  81. 6.14.2 Kaneka Eurogentec SA Business Overview
  82. 6.14.3 Kaneka Eurogentec SA Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Kaneka Eurogentec SA Peptide Conjugates Service Product Portfolio
  84. 6.14.5 Kaneka Eurogentec SA Recent Developments
  85. 6.15 QYAOBIO
  86. 6.15.1 QYAOBIO Company Information
  87. 6.15.2 QYAOBIO Business Overview
  88. 6.15.3 QYAOBIO Peptide Conjugates Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 QYAOBIO Peptide Conjugates Service Product Portfolio
  90. 6.15.5 QYAOBIO Recent Developments
7 North America
  1. 7.1 North America Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Peptide Conjugates Service Market Size by Country (2021-2026)
  3. 7.3 North America Peptide Conjugates Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Peptide Conjugates Service Market Size by Country (2021-2026)
  3. 8.3 Europe Peptide Conjugates Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Peptide Conjugates Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Peptide Conjugates Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Peptide Conjugates Service Market Size by Country (2021-2026)
  3. 10.3 South America Peptide Conjugates Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Peptide Conjugates Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Peptide Conjugates Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Peptide Conjugates Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst